Close-up of microscope and sample with blue glove.

Funding excellent research

Aiming for a life without EB

EB Resnet supports and coordinates research funding on behalf of its member patient organisations and partners. We currently offer three funding schemes: Research grants through scheduled Calls for proposals, Ad-hoc grants our flexible funding scheme, and Co-funding for industry-partnering projects.

EB Resnet welcomes proposals for innovative research and clinical development of treatments or diagnostics. All proposals are evaluated for scientific excellence, feasibility and value for money, and whether they address the priority needs of people with EB. We undertake peer review to ensure that only the best research is funded.

Our funding schemes. How do your ideas fit in?

Research grants	Ad-hoc grants	Industry co-funding
You are engaged in fundamental to preclinical research or clinical trials in EB Your project idea falls within the scope of a Current /Closed Special Call (All priorities Call or Special Call in spring and/or autumn) You are working in academia, or in a clinic (cooperation with industry welcome) Your project objectives can be achieved in 12 to 36 months and financed with up to EUR 90,000.00 p.a.	You are engaged in fundamental research to preclinical or clinical trials in EB You are in need of quick funding to respond to an arising opportunity in fundamental to preclinical research or proof of concept project Your project idea falls within the scope of a Special Ad-hoc Call You are working in academia, in a clinic or in industry Your project can be undertaken within one year (renewable if results are promising) and financed with up to EUR 100,000.00 p.a.	You are engaged in translational research and undertaking clinical trials in EB Your project is in late preclinical to clinical stage You are working in the industry and/or in cooperation with academia The project needs additional funding of up to EUR 250,000.00 to be realised

Research grants

Ad-hoc grants

Industry co-funding

Joint Funding Call

EB Repurposing 2023

EOI CLOSED

Open

Open

You are engaged in fundamental to preclinical research or clinical trials in EB
Your project idea falls within the scope of a Current /Closed Special Call (All priorities Call or Special Call in spring and/or autumn)
You are working in academia, or in a clinic (cooperation with industry welcome)
Your project objectives can be achieved in 12 to 36 months and financed with up to EUR 90,000.00 p.a.

You are engaged in fundamental research to preclinical or clinical trials in EB
You are in need of quick funding to respond to an arising opportunity in fundamental to preclinical research or proof of concept project
Your project idea falls within the scope of a Special Ad-hoc Call
You are working in academia, in a clinic or in industry
Your project can be undertaken within one year (renewable if results are promising) and financed with up to EUR 100,000.00 p.a.

You are engaged in translational research and undertaking clinical trials in EB
Your project is in late preclinical to clinical stage
You are working in the industry and/or in cooperation with academia
The project needs additional funding of up to EUR 250,000.00 to be realised

Special Call 2023, and Outcomes of closed Calls 2022

This year's Special Call is focusing on chronic inflammation and fibrosis (CIF), cancer initiation & repurposing, which EB Resnet member DEBRA Austria is jointly funding with LifeArc. More information is available under Joint Call 2023 Repurposing therapies for EB.

The AP Call and the Special Ad-hoc Call from 2022 have both been completed. Results of the funded projects can be found in the overview tables 2022.

Special Call 2023

Joint Call 2023: Repurposing therapies for EB - EOI CLOSED

Closed Call

AP Call 2022

Our funding schemes in detail

Three pipettes with colored liquids, one is lifted up.

Research grants

There are up to two calls for proposals each year, focused on specific topics or across all EB Resnet priority areas.

Current grant rounds

Ad-hoc grants

Ad-hoc grants may be applied for when there is a specific immediate need for project funding, or a time-limited opportuntity for co-funding arises.

Learn more about Ad-hoc grants

Two pipettes with yellow and blue liquides.

Industry co-funding

Cooperation with industry partners is becoming essential as successful research is progressing rapidly to clinical translation.

How we co-fund industry

Screen of a laptop with two hands working on it.

Application & funding process

The three funding schemes available provide funding opportunities for different groups and projects. Check how the funding process works.

How to apply

Good to know before applying for a grant

EB girl looking through a microscope in an EB lab.

Research priorities

All proposals must meet at least one of EB Resnet's research priorities.

Our research priorities

Terms & conditions, revenue sharing

Before you apply for a grant please check our terms & conditions.

Read our terms & conditions

Current call

Special Call 2023

LifeArc and DEBRA Austria launch £2.5m funding call for repurposing therapies for Epidermolysis Bullosa

More information

Find out more about funded projects

Keratin 14 Intermediärfilament von humanen Keratinozyten

Project portfolio

Find here an overview of ongoing and completed EB research projects, mainly funded by EB Resnet members.

See project portfolio

Project map

Locate EB research projects on our project map. There is a lot going on worldwide.

View project map